BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stanke-Labesque F, Gautier-Veyret E, Chhun S, Guilhaumou R; French Society of Pharmacology and Therapeutics. Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment. Pharmacol Ther 2020;215:107627. [PMID: 32659304 DOI: 10.1016/j.pharmthera.2020.107627] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Tziastoudi M, Pissas G, Raptis G, Cholevas C, Eleftheriadis T, Dounousi E, Stefanidis I, Theoharides TC. A Systematic Review and Meta-Analysis of Pharmacogenetic Studies in Patients with Chronic Kidney Disease. Int J Mol Sci 2021;22:4480. [PMID: 33923087 DOI: 10.3390/ijms22094480] [Reference Citation Analysis]
2 Kinoshita Y, Ueno H, Kurata H, Ikeda C, Hori E, Okada T, Shimazu T, Fujii I, Matsukura M, Imamura H, Moschovi M. Infection-Induced Elevated Plasma Perampanel in a Patient with Hemimegalencephaly. Case Reports in Pediatrics 2022;2022:1-6. [DOI: 10.1155/2022/9844820] [Reference Citation Analysis]
3 Marie S, Hernández-lozano I, Le Vée M, Breuil L, Saba W, Goislard M, Goutal S, Truillet C, Langer O, Fardel O, Tournier N. Pharmacokinetic Imaging Using 99mTc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in Rats. Pharmaceuticals 2022;15:392. [DOI: 10.3390/ph15040392] [Reference Citation Analysis]
4 Berman E, Noyman I, Medvedovsky M, Ekstein D, Eyal S. Not your usual drug-drug interactions: Monoclonal antibody-based therapeutics may interact with antiseizure medications. Epilepsia 2021. [PMID: 34967010 DOI: 10.1111/epi.17147] [Reference Citation Analysis]
5 Lenoir C, Rollason V, Desmeules JA, Samer CF. Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the Literature. Front Pharmacol 2021;12:733935. [PMID: 34867341 DOI: 10.3389/fphar.2021.733935] [Reference Citation Analysis]
6 Agostino M, Rooney J, Herat L, Matthews J, Simonds A, Northfield SE, Hopper D, Schlaich MP, Matthews VB. TNFSF14-Derived Molecules as a Novel Treatment for Obesity and Type 2 Diabetes. Int J Mol Sci 2021;22:10647. [PMID: 34638990 DOI: 10.3390/ijms221910647] [Reference Citation Analysis]
7 Bryche B, Baly C, Meunier N. Modulation of olfactory signal detection in the olfactory epithelium: focus on the internal and external environment, and the emerging role of the immune system. Cell Tissue Res 2021;384:589-605. [PMID: 33961125 DOI: 10.1007/s00441-021-03467-y] [Reference Citation Analysis]
8 Chavant A, Fonrose X, Gautier-Veyret E, Hilleret MN, Roustit M, Stanke-Labesque F. Variability of Tacrolimus Trough Concentration in Liver Transplant Patients: Which Role of Inflammation? Pharmaceutics 2021;13:1960. [PMID: 34834375 DOI: 10.3390/pharmaceutics13111960] [Reference Citation Analysis]
9 Doudka N, Giocanti M, Basso M, Ugdonne R, Barthelemy K, Lacarelle B, Blin O, Solas C, Guilhaumou R. Development and Validation of a Simple and Rapid Ultrahigh-Performance Liquid Chromatography Tandem Spectrometry Method for the Quantification of Hydroxychloroquine in Plasma and Blood Samples in the Emergency Context of SARS-CoV-2 Pandemic. Ther Drug Monit 2021;43:570-6. [PMID: 33165216 DOI: 10.1097/FTD.0000000000000836] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Saib S, Delavenne X. Inflammation Induces Changes in the Functional Expression of P-gp, BCRP, and MRP2: An Overview of Different Models and Consequences for Drug Disposition. Pharmaceutics 2021;13:1544. [PMID: 34683838 DOI: 10.3390/pharmaceutics13101544] [Reference Citation Analysis]
11 Zhao Y, Kong W, Wang P, Song G, Song ZL, Yang Y, Wang Y, Yin B, Rong P, Huan S, Zhang XB. Tumor-Specific Multipath Nucleic Acid Damages Strategy by Symbiosed Nanozyme@Enzyme with Synergistic Self-Cyclic Catalysis. Small 2021;17:e2100766. [PMID: 34110695 DOI: 10.1002/smll.202100766] [Reference Citation Analysis]
12 de Jong LM, Jiskoot W, Swen JJ, Manson ML. Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Potential Role for Pharmacogenetics. Genes (Basel) 2020;11:E1509. [PMID: 33339226 DOI: 10.3390/genes11121509] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
13 Lenoir C, Terrier J, Gloor Y, Gosselin P, Daali Y, Combescure C, Desmeules JA, Samer CF, Reny J, Rollason V. Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting. JPM 2022;12:526. [DOI: 10.3390/jpm12040526] [Reference Citation Analysis]
14 Imai T, Ochiai S, Ishimaru T, Daitoku H, Miyagawa Y, Fukuhara R, Boku S, Takebayashi M. A case report: Clozapine‐induced leukopenia and neutropenia after mRNA COVID‐19 vaccination. Neuropsychopharm Rep. [DOI: 10.1002/npr2.12238] [Reference Citation Analysis]
15 Bousman CA, Bengesser SA, Aitchison KJ, Amare AT, Aschauer H, Baune BT, Asl BB, Bishop JR, Burmeister M, Chaumette B, Chen L, Cordner ZA, Deckert J, Degenhardt F, Delisi LE, Folkersen L, Kennedy JL, Klein TE, Mcclay JL, Mcmahon FJ, Musil R, Saccone NL, Sangkuhl K, Stowe RM, Tan E, Tiwari AK, Zai CC, Zai G, Zhang J, Gaedigk A, Müller DJ. Review and Consensus on Pharmacogenomic Testing in Psychiatry. Pharmacopsychiatry 2021;54:5-17. [DOI: 10.1055/a-1288-1061] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
16 Carton L, Bordet R, Montastruc F, Guilhaumou R. Towards personalized pharmacology: Antipsychotics and schizophrenia. Therapie 2021;76:137-47. [PMID: 33423786 DOI: 10.1016/j.therap.2020.12.010] [Reference Citation Analysis]
17 Edinoff AN, Fort JM, Woo JJ, Causey CD, Burroughs CR, Cornett EM, Kaye AM, Kaye AD. Selective Serotonin Reuptake Inhibitors and Clozapine: Clinically Relevant Interactions and Considerations. Neurol Int 2021;13:445-63. [PMID: 34564289 DOI: 10.3390/neurolint13030044] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Thompson D, Delorme CM, White RF, Honer WG. Elevated clozapine levels and toxic effects after SARS-CoV-2 vaccination. J Psychiatry Neurosci 2021;46:E210-1. [PMID: 33667055 DOI: 10.1503/jpn.210027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
19 Campesi I, Racagni G, Franconi F. Just a Reflection: Does Drug Repurposing Perpetuate Sex-Gender Bias in the Safety Profile? Pharmaceuticals (Basel) 2021;14:730. [PMID: 34451827 DOI: 10.3390/ph14080730] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Moschny N, Hefner G, Grohmann R, Eckermann G, Maier HB, Seifert J, Heck J, Francis F, Bleich S, Toto S, Meissner C. Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs-Influence of Smoking Behavior and Inflammation on Pharmacokinetics. Pharmaceuticals (Basel) 2021;14:514. [PMID: 34071813 DOI: 10.3390/ph14060514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Launay M, Demartin AL, Ragey SP, Mismetti P, Botelho-Nevers E, Delavenne X. Severe Inflammation, Acute Kidney Injury, and Drug-Drug Interaction: Triple Penalty for Prolonged Elimination of Apixaban in Patients With Coronavirus Disease 2019: A Grand Round. Ther Drug Monit 2021;43:455-8. [PMID: 33908408 DOI: 10.1097/FTD.0000000000000899] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Stanke-Labesque F, Concordet D, Djerada Z, Bouchet S, Solas C, Mériglier E, Bonnet F, Mourvillier B, Ruiz S, Martin-Blondel G, Epaulard O, Schwebel C, Gautier-Veyret E, Gandia P. Neglecting Plasma Protein Binding in COVID-19 Patients Leads to a Wrong Interpretation of Lopinavir Overexposure. Clin Pharmacol Ther 2021;109:1030-3. [PMID: 33547636 DOI: 10.1002/cpt.2196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 White CM. Inflammation Suppresses Patients' Ability to Metabolize Cytochrome P450 Substrate Drugs. Ann Pharmacother 2021;:10600280211047864. [PMID: 34590872 DOI: 10.1177/10600280211047864] [Reference Citation Analysis]
24 Bolcato L, Khouri C, Veringa A, Alffenaar JWC, Yamada T, Naito T, Lamoureux F, Fonrose X, Stanke-Labesque F, Gautier-Veyret E. Combined Impact of Inflammation and Pharmacogenomic Variants on Voriconazole Trough Concentrations: A Meta-Analysis of Individual Data. J Clin Med 2021;10:2089. [PMID: 34068031 DOI: 10.3390/jcm10102089] [Reference Citation Analysis]
25 Wang X, Ye C, Xun T, Mo L, Tong Y, Ni W, Huang S, Liu B, Zhan X, Yang X. Bacteroides Fragilis Polysaccharide A Ameliorates Abnormal Voriconazole Metabolism Accompanied With the Inhibition of TLR4/NF-κB Pathway. Front Pharmacol 2021;12:663325. [PMID: 33995087 DOI: 10.3389/fphar.2021.663325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Le Daré B, Boglione-Kerrien C, Reizine F, Gangneux JP, Bacle A. Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis. Crit Care 2021;25:152. [PMID: 33879175 DOI: 10.1186/s13054-021-03568-8] [Reference Citation Analysis]
27 Chavant A, Gautier-Veyret E, Chhun S, Guilhaumou R, Stanke-Labesque F. [Pharmacokinetic changes related to acute infection. Examples from the SARS-CoV-2 pandemic]. Therapie 2021;76:319-33. [PMID: 33129512 DOI: 10.1016/j.therap.2020.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Lenoir C, Niederer A, Rollason V, Desmeules JA, Daali Y, Samer CF. Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics. CPT Pharmacometrics Syst Pharmacol 2021. [PMID: 34791831 DOI: 10.1002/psp4.12730] [Reference Citation Analysis]
29 Novelli M, Masiello P, Beffy P, Menegazzi M. Protective Role of St. John's Wort and Its Components Hyperforin and Hypericin against Diabetes through Inhibition of Inflammatory Signaling: Evidence from In Vitro and In Vivo Studies. Int J Mol Sci 2020;21:E8108. [PMID: 33143088 DOI: 10.3390/ijms21218108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
30 Gautier-Veyret E, Thiebaut-Bertrand A, Roustit M, Bolcato L, Depeisses J, Schacherer M, Schummer G, Fonrose X, Stanke-Labesque F. Optimization of voriconazole therapy for treatment of invasive aspergillosis: Pharmacogenomics and inflammatory status need to be evaluated. Br J Clin Pharmacol 2021;87:2534-41. [PMID: 33217017 DOI: 10.1111/bcp.14661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Lemaitre F. Médiateurs de l’inflammation : le chaînon manquant de la variabilité pharmacocinétique ? Therapie 2021;76:317-8. [PMID: 33339629 DOI: 10.1016/j.therap.2020.12.001] [Reference Citation Analysis]